United States Viscosupplementation Market Sees High Growth Owing To Increasing Knee Osteoarthritis Prevalence

 


The United States viscosupplementation market comprises injectable hyaluronic acid viscosupplementation products used for the treatment of knee osteoarthritis. Knee osteoarthritis is a common form of arthritis that causes pain, swelling, and stiffness in the knee joint. It occurs when cartilage cushions in the knees break down and wear away over time. The deteriorating cartilage no longer acts as padding between bones, resulting in bone rubbing against bone and intense knee joint pain. Viscosupplementation products mimic normal hyaluronic acid in the knee joint and act as lubricants to reduce pain and increase mobility. The growth in the elderly population in the United States and the rise in sedentary lifestyles leading to overweight and obesity have increased the number of individuals suffering from knee osteoarthritis. This has driven the demand for viscosupplementation injections as a minimally invasive option for pain management and improved mobility.

The United States viscosupplementation market is estimated to be valued at US$ 1.54 Bn in 2024 and is expected to exhibit a CAGR of 8.1% over the forecast period 2024-2031.

 Key Takeaways

Key players operating in the United States viscosupplementation market are Anika Therapeutics Inc., Ferring Pharmaceuticals, Bioventus, Fidia Farmaceutici S.P.A., Mylan N.V., Sanofi S.A., Teva Pharmaceutical Industries Ltd, Johnson & Johnson., F. Hoffmann-La Roche AG, and Zimmer Biomet. These players account for majority of the market share and focus on introducing advanced single and multi-injection hyaluronic acid products.

Key opportunities in the market include increased adoption of multi-dose, longer-lasting viscosupplementation injections to improve patient compliance and outcomes. Additionally, expanding Medicare insurance coverage for viscosupplementation can further aid market growth.

Globally, companies are eyeing strategic expansion opportunities in Asian and European countries through licensing agreements and partnerships. The market in Asia Pacific is expected to exhibit high growth rates owing to large target populations and increasing acceptance of hyaluronic acid therapies.

Market Drivers

Rising geriatric population: The growth in elderly demography above 65 years is driving increased prevalence of knee osteoarthritis. This age group experiences higher risks of knee cartilage degeneration and joint pain.

Increasing obesity rates: Growing prevalence of obesity in the United States has resulted in associated health issues like knee osteoarthritis. Obesity places additional pressure on knees and accelerates cartilage damage over time.

Market Restraints

Preference for non-drug therapies: Alternative pain management options like exercise, weight management, and physical therapy continue to gain popularity. This may limit complete dependence on viscosupplementation injections.

Cost barriers: High treatment costs associated with multivial viscosupplementation regimens can pose affordability challenges for many. This is a key challenge to maximize treatment penetration.

Segment Analysis

The United States of America viscosupplementation market is dominated by three-injection and five-injection viscosupplementation sub segments.

The three-injection viscosupplementation sub segment holds the largest market share as it provides immediate pain relief and requires fewer doctor visits. Its effectiveness in treating knee osteoarthritis with minimum side effects makes it the preferred treatment option.

Global Analysis

The North America region accounts for the largest share in the United States of America viscosupplementation market owing to high prevalence of osteoarthritis and presence of major players in the region. The region is expected to maintain its dominance during the forecast period due to strong reimbursement policies, growing geriatric population and increasing obesity rates. Europe is the second largest viscosupplementation market due to rising awareness about viscosupplementation treatments and availability of advanced healthcare facilities. However, Asia Pacific region is projected to grow at the fastest rate during the forecast period due to improving healthcare infrastructure and rapidly increasing medical tourism in the region.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it

 

Get more insights on this topic:  https://www.ukwebwire.com/united-states-viscosupplementation-market-estimated-to-witness-high-growth-owing-to-increasing-demand-for-knee-arthroscopy-procedures/

 

Author Bio:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163 )

What Are The Key Data Covered In This United States of America Viscosupplementation  Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the United States of America Viscosupplementation 's growth between 2024 and 2031.

:- Accurate calculation of the size of the United States of America Viscosupplementation  and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- United States of America Viscosupplementation  Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of United States of America Viscosupplementation  vendors

FAQ’s

Q.1 What are the main factors influencing the United States of America Viscosupplementation ?

Q.2 Which companies are the major sources in this industry?

Q.3 What are the market’s opportunities, risks, and general structure?

Q.4 Which of the top United States of America Viscosupplementation  companies compare in terms of sales, revenue, and prices?

Q.5 Which businesses serve as the United States of America Viscosupplementation ’s distributors, traders, and dealers?

Q.6 How are market types and applications and deals, revenue, and value explored?

Q.7 What does a business area’s assessment of agreements, income, and value implicate?

Comments

Popular posts from this blog

United States Candy : A Sweet Tradition

United Kingdom Pelargonic Acid : Pelargonic Acid Dynamics In The United Kingdom

United Kingdom Gas Leak Detector : Ensuring Safety In Homes And Businesses